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An Injectable Hydrogel as Bone Graft Material
with Added Antimicrobial Properties
Giacomo Tommasi, MEng, Stefano Perni, PhD, and Polina Prokopovich, PhD
Currently, the technique which provides the best chances for a successful bone graft, is the use of bone tissue
from the same patient receiving it (autograft); the main limitations are the limited availability and the risks
involved in removing living bone tissue, for example, explant site pain and morbidity. Allografts and xenografts
may overcome these limitations; however, they increase the risk of rejection. For all these reasons the de-
velopment of an artificial bone graft material is particularly important and hydrogels are a promising alternative
for bone regeneration. Gels were prepared using 1,4-butanediol diacrylate as crosslinker and alpha tri-
calciumphosphate; ZnCl2 and SrCl2 were added to the aqueous phase. MTT results demonstrated that the
addition of strontium had a beneficial effect on the osteoblast cells density on hydrogels, and zinc instead did
not increase osteoblast proliferation. The amount of calcium produced by the osteoblast cells quantified through
the Alizarin Red protocol revealed that both strontium and zinc positively influenced the formation of calcium;
furthermore, their effect was synergistic. Rheology properties were used to mechanically characterize the
hydrogels and especially the influence of crosslinker’s concentration on them, showing the hydrogels presented
had extremely good mechanical properties. Furthermore, the antimicrobial activity of strontium and zinc in the
hydrogels against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis was determined.
Introduction
Bone is a rigid, mineralized connective tissue and itsmain function is to protect organs and give support to the
body. Therefore, bones are fundamental for locomotion, but
they also provide other important functions, such as regulat-
ing homeostatis of calcium and provide a source of hema-
topoietic stem cells.1 These different functions are related
macroscopically to two different forms: compact (cortical)
bone and trabecular (cancellous or spongy) bone. The first
appears as a solid mass, represent 80% of the mass of an adult
human,2 has a porosity of 5%,3 and has the function of pro-
tection and support. The trabecular bone appears as a sponge,
with 90% porosity,3 whose free spaces are filled with bone
marrow and is mainly responsible for mineral homeostasis.4,5
Bone matrix is composed for 77% by inorganic material
(90% calcium phosphate) and for only 23% by organic
material, most of which (89%) is type I collagen.3
Bone provides solid support to the body structure and is
an organ that acts as a reservoir for critical ions such as
calcium and phosphate, but it also plays an important role
for the immune system; in actual fact, immune cells (T cells,
B cells, and natural killer [NK] cells) are produced in the
bone marrow and the interaction between immune cells and
bone is classified as osteoimmunology.6
Unfortunately, bones are often subjected to injuries due to
sports or in the workplace along with trauma commonly
related to road traffic accidents2 and diseases such as tu-
mors.7,8 The treatment of these conditions often requires the
use of bone grafts in all those cases in which bone cannot
self-repair and must be substituted.9 Today, the technique
that gives the best results in terms of integration and new
bone formation is the autograft (the transplant of bone tis-
sues from the same patient).
Bone is the second most common transplanted tissue after
blood, with the iliac crest autologous graft being most used.6
For this reason, autologous bone graft is considered the gold
standard for treatment of bone defects, but several drawbacks
exist.10,11 The main limitations of this procedure are the lim-
ited availability and the risks involved in removing living bone
tissue, for example, explant site pain and morbidity.11 Allo-
grafts and xenograftsmayovercome these limitations, but they
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increase the risk of rejection since the host’s immune system
may recognize the graft as a nonself tissue6,10; furthermore,
ethical issues surround the acceptance by a patient of having
implanted tissue originated from another human being or an
animal. For all these reasons the development of an artificial
bone graft is particularly important and bone tissue engi-
neering is a promising alternative for bone regeneration.
Synthetic graft substitutes combine scaffolding properties
with biological elements to stimulate cells proliferation and
differentiation and eventually osteogenesis.6 They may de-
termine a significant improvement in the restorative treatment
and healthcare expenses of degenerative bone conditions,
deformities, injuries, or intentional loss (e.g., cancer resec-
tion).2 In 2010, the sales in bone graft substitutes were valued
at $1.3 billion in the United States, with a forecast of $2.3
billion in 2017.12 It is estimated that 2.2 million of orthopedic
procedures worldwide employ bone grafts annually.13
During the last 15 years great effort has been dedicated to the
use of hydrogels as a material for bone regeneration12 and
cartilages.14,15 Hydrogels are materials that swell, but do not
dissolve in water, maintaining a distinct 3D network structure
by virtue of crosslinks16,17 and their high content of water let
themmimic the composition of biological tissues. On the other
hand, their mechanical properties are generally poor and can-
not be applied in load-bearing situation; to date, none of the
bone substitutes proposed is load bearing.18 Therefore, when
required, the mechanical support is provided by fixation de-
vices.19 Hydrogels are particularly interesting because they can
be used to deliver cells, drugs, or proteins. In fact, several
different combinations of hydrogels and additives have been
studied andmany of themdemonstrated promising results.20–24
However, the main reasoning for research, focusing on hy-
drogels for bone regeneration, is their injectability.1 The main
advantage of injectable materials compared to 3D scaffold is
that they can be applied using noninvasive or minimally in-
vasive surgeries and they can fill irregularly shaped bone de-
fects easily. Therefore, using an injectable hydrogel, instead of
an autologous bone graft, has a double advantage: the primary
surgery to implant the gel would be noninvasive and the sec-
ondary surgery to explant the graft would be avoided. In the
development of injectable hydrogels, two main classes of
materials have been used, natural and synthetic polymers.1
Hyaluronate-25,26 and chitosan-27 based hydrogel are examples
of the former type, whereas PEG-28–30 and PLGA-31 based
hydrogels belong to the latter type.
We have previously developed synthetic bone graft
PEG-based hydrogels using acrylate monomers [PEGMEM
(poly(ethylene glycol) methyl ether methacrylate), DEM (2-
(dimethylamino)ethyl methacrylate)] crosslinked with N-N¢-
methylenebisacrylamide32,33 that exhibited high mechanical
properties, whereas calcium phosphate particles were formed
inside the gelmatrix, postgelification, using a reaction–diffusion
method. In this work, we developed and in vitro tested a new
acrylate-based hydrogels adding calcium phosphate directly in
the gelifying solution and such not requiring the additional step
of the reaction–diffusion process. Furthermore, injectability was
conferred by the use of a diacrylate ester as crosslinker instead of
N-N¢-methylenebisacrylamide32,33 that requires the removal of
unreacted molecules through time-consuming dialysis. We also
added Zn and Sr to the hydrogels as they are known to enhance
osteoblast growth34 and demonstrate that these ions also confer
antimicrobial properties to the material.
Materials and Methods
Materials
PEGMEM [poly(ethylene glycol) methyl ether methacry-
late] with average Mn = 300, DEM [2-(dimethylamino)ethyl
methacrylate], 1,4-butanediol dimethacrylate, ammonium
persulfate (APS), ZnCl2, SrCl2, glutaraldehyde, acetic acid,
Thiazolyl Blue Tetrazolium Bromide (MTT), and Alizarin
Red S were purchased from Sigma-Aldrich. a-Tricalcium-
phosphate (a-TCP) was purchased from Fluka.
Simulated body fluid (SBF) solution was prepared according
to British Standard ISO 23317:200.
Gram-positive bacteria, methicillin-resistant Staphylo-
coccus aureus (MRSA)—MRSA (NCTC 12493) and Sta-
phylococcus epidermidis (RP62a), were used. Bacteria frozen
stocks were stored at -80C; weekly, strains were streaked
out on Brain Heart Infusion (BHI) plates (Oxoid) and in-
cubated for 24 h at 37C and then stored at 4C.
Hydrogel preparation
Hydrogel samples were prepared mixing 2mL of PEG-
MEM, 1mL of DEM, and 1,4-butanediol diacrylate as
crosslinker in different concentrations: 1%, 5%, 10%, 20% (v/
v) in 5mLof deionizedwater containing 2mg/mL ofAPS and
10mg/mL of a-TCP. When required, ZnCl2 and SrCl2 were
added to the aqueous phase at various concentrations (100 or
50mM for SrCl2 and 0.5 or 1mM for ZnCl2), individually or
together. Gels were prepared in 10-mL plastic syringes and,
once polymerized, the top of syringes were cut and gels were
pushed out from the syringe shaft using the plunger.
Physicochemical characterization of hydrogels
Temperature profile during polymerization. The poly-
merization stage is an exothermic reaction. It means that
during polymerization, energy is released and the material
increases its temperature. To quantify this increment, the
temperature has been monitored during gelification through
the insertion of a thermocouple in the gel. Gels were prepared
directly inside 50-mL plastic falcon tubes, in which the
thermocouple (EKT 3001; Heidolph) was inserted carefully
preventing touching the tube walls. Temperature was re-
corded everyminute for 40min sincemixing of themonomers
with the water solution containing APS. For this test, three
independent gels with 1% and 20% v/v crosslinking agent
were prepared.
Swelling test. Hydrogels after polymerization were then
cut into smaller pieces and put in glass bottles containing
phosphate-buffered solution (PBS) and incubated at 37C.
Gels were weighted before the immersion in 5mL of PBS
and at different time points: every day for the first 21 days,
twice a week for the next 50 days, and once a week after-
ward. At least three individual samples were weighted and
averaged for each condition.
The swelling ratio (H) was calculated as a percentage
variation of the initial weight according to:
H¼ mf
mi
· 100 (1)
where: mi is weight of the gel before swelling, mf is weight
of the gel after swelling.
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Freshly made samples were employed to avoid the pos-
sibility of drying when in contact with the atmosphere. The
test was performed on three independently prepared samples
and results are presented as mean – standard deviation (SD).
Rheology. Rheology tests were performed to characterize
the time required to achieve gelification and the mechanical
properties of gels, especially the influence of crosslinker’s
concentration.
The time required by the hydrogel to form was deter-
mined as the time needed by the phase angle to drop to zero,
and for this, an aliquot of about 100 mL of the suspension
before gelification started was put in the rheometer (AR-G2;
TA Instruments) plate and time sweep mode was used at a
frequency of 1Hz for 1200 s period.
Hydrogels were stored in PBS for 14 days at 37C and
then they were cut into a circle through a stamp of 25mm
diameter and loaded into the rheometer; the frequency
sweep mode (from 10 to 0.01Hz) was employed for the
determination of the rheological properties of the hydrogels.
All tests were performed at a controlled temperature of
37C with a 25-mm serrated parallel plate (Peltier plate made
of aluminum) to prevent slippage sandwiching the material at
a constant, but low normal force (5N); measurements were
conducted at a strain of 0.1%, which was within the linear
viscoelastic range of the material, as confirmed by a strain
sweep and the absence of a third harmonic response.
X-ray diffraction. Samples prepared as for swelling test
remained immersed in SBF at 37C for 1 month. Before
analysis, samples were removed from the SBF and freeze
dried for 24 h at -40C using an Edwards Modulyo Freeze
Dryer. X-ray diffraction (XRD) patterns were acquired us-
ing a Philips PW1710 Automated Powder Diffractometer
and samples were run over a 2y range between 10 and 60 at
a scan speed of 0.016/s.
Scanning electron microscope. Samples of gels freshly
prepared and after 1 month in SBF were analyzed with
scanning electron microscope (SEM) (Gemini, Zeiss
1540xb; Oxford Instruments). Before the analysis all sam-
ples were freeze dried for 24 h. The applied voltage used
was between 3 and 5 kV; the range of magnifications used
was from a minimum of 40· to a maximum of 10,000·.
Ion release. Ion release test was performed to determine
the concentration of Sr and Zn ions released from the gels
with 1% and 20% v/v of crosslinker, with 50 or 100mM Sr
and a combination of 100mM of Sr and 1mM of Zn. Gels
were prepared in plastic syringes and after gelification were
cut in smaller pieces and immersed in 5mL of PBS inside
glass bottles. Bottles were incubated at 37C. For every time
point, samples were transferred in 5mL of fresh PBS, while
the whole solution in which they were immersed was diluted
at a ratio of 4:1 with PBS and analyzed with spectrometer
(Optima 2100 DV; PerkinElmer). Calibration was per-
formed with 28-element Standard (Fisher Scientific);
strontium was detected with 407.771 nm filter, whereas zinc
was detected with 206.200 nm filter. The test was performed
on three independently prepared samples and results are
presented as mean – SD.
Osteoblast cell growth on hydrogels
Osteoblast cells (MC-3T3) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with fetal
bovine serum (10% v/v) and 1% v/v of a solution of peni-
cillin (5000U/mL)/streptomycin (5000mg/mL); cells were
incubated at 37C in humidified atmosphere with 5% CO2.
Cells were grown till*70% confluence, washed twice with
sterile PBS, and detached with trypsin; osteoblast cells were
counted (using Trypan Blue to differentiate between viable
and nonviable cells) and diluted to a concentration *105
cells/mL with fresh medium.
Gels were prepared directly in round-bottom 96-well
plates, for a total volume of 100 mL of gel per well and stored
at room temperature for 24 h before cells were put in contact
with. Each well was filled with 100mL of cell suspension
containing about 10,000 mouse osteoblast (MC-3T3) cells in
DMEMmedium. Plates were incubated at 37C in humidified
atmosphere with 5%CO2; mediumwas regularly changed for
21 days when MTT and Alizarin Red tests were carried out.
The test was performed in triplicates on three independently
prepared samples and results are presented as mean – SD.
Thiazolyl Blue Tetrazolium Bromide (MTT). The medium
present in the well was taken off and replaced with 100mL
of fresh medium (phenol red-free). Ten microliters of
Thiazolyl Blue Tetrazolium Bromide 5mg/mL in PBS was
added to each well and the plate was incubated for 2 h at
37C in humidified atmosphere with 5% CO2; after this
50 mL of dimethyl sulfoxide (DMSO) was added and the
plates were incubated for further 10min. Eighty microliters
of solution containing the dissolved formazan was put in
another 96-well plate and analyzed with a spectrophotom-
eter (LabTech LT5000MS) at 560 nm.
Alizarin Red. The medium present in the well was taken
off and replaced with 100 mL of glutaraldehyde 10% (v/v);
the plates were incubated for 15min and washed with
deionized water. One hundred microliters of Alizarin Red S
1% (v/v) was added to each well and the plates were incu-
bated for 20min. After washing with deionized water,
150 mL of acetic acid 10% (v/v) was added to each well and
the plates were incubated for 30min. After this, 20 mL of
solution was put in another 96-well plate, diluted with 80mL
of deionized water, and analyzed with a spectrophotometer
(LabTech LT5000MS) at 450 nm.
Controls samples consisting of unseeded gels were used
as control for Alizarin Red test because of the presence of
calcium in the hydrogels through a-TCP.
Antimicrobial activity of hydrogels
Gels were prepared directly inside a 24-well plate and for
each well a total of 1mL of gel was used. Once the gels
were formed, 1.5mL of bacterial broth suspension, obtained
by incubating statically 10mL of fresh sterile BHI broth
(Oxoid) for 24 h at 37C after inoculating with a loopful of
cells, was put into each well. Bacteria were left in contact
with the gels in the incubator at 37C for 1 h. After incu-
bation, the suspension was removed and the gel was washed
three times with 1mL of sterile PBS. Wells were then filled
with 1.5mL of solution composed by 10% of sterile BHI
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broth and 90% of sterile PBS and finally incubated at 37C.
After 24 h, 50mL of suspension from each well was mixed
with 100mL of fresh BHI broth placed in 100-well plates
and growth curves at 37C were recorded and analyzed
using Bioscreen plate reader. Optical density at 600 nm of
each individual well was recorded every 15min for a total
of 24 h.
Tests were performed in triplicate from three independent
cultures for a total of nine growth curves for each bacterium
on each gel. Each growth curve was fitted using the Gom-
pertz growth model to extract values of lag phase and
growth rate. Results are presented as mean and standard
deviation.
Statistical analysis
Data were analyzed using one-way ANOVA to determine
any significant difference between the mean values, and this
was followed by Tukey’s post hoc test ( p < 0.05). Statistical
analysis was performed using SPSS.
Results
Temperature profile during polymerization
The temperature profile during polymerization of the
hydrogels showed that gels with 1% of crosslinker had a
higher temperature increment than those with 20%, during
polymerization (Fig. 1). Similarly, the presence of strontium
in both gels, with 1% and 20% of crosslinker, did not change
the temperature profile significantly. The monomers and
crosslinker were mixed at room temperature, and tempera-
ture rose in the first 10min as a result of the exothermic
polymerization reaction, and later the temperature gradually
decreased.
Polymerization time
The time needed to form the gel was determined from
rheological tests of phase angle in time sweep mode; when
the phase angle between storage and loss modulus reaches a
value close to 0 the material was completely gelled. In
Figure 2 it can be noticed that every gel reached a phase
angle of about 0 in 100–300 s, this time slightly de-
creased with increasing content of crosslinker. For gels with
>10% v/v of crosslinking agents, the phase angle was very
high at the point of mixing and decreased with advancing
polymerization.
Swelling
As can be seen from the graphs (Fig. 3), water uptake for all
hydrogels reached a maximum after about 10 days of im-
mersion; as expected, the lower the concentration of cross-
linker, the higher the swelling. When 1% v/v crosslinker was
used, the gels almost doubled their weight, whereas the gels
containing 20% v/v of crosslinking agent increased their
weight of 50%. After the first 2 weeks the weight of the
samples remained constant for the remaining duration of the
test (up to 90 days) for gels with crosslinker concentration
FIG. 1. Temperature profile during polymerization as
function of crosslinker concentration and presence of Sr
ions. 1% B 20% ; 1%+ Sr 100mM 6 20%+ Sr 100mM
FIG. 2. Variation of phase angle as function of crosslinker
concentration during polymerization. 1% B 5% ; 10% 6 20%
FIG. 3. Influence of crosslinker concentration on water
adsorption of hydrogels over time. 1% B 5% ; 10% 6 20%
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<10% v/v; gels prepared with 20% v/v exhibited a weight
drop probably in virtue of the hydrolysis of the ester bonds
present in the crosslinking molecule that resulted in the ac-
rylate chains being released from the solid gel.
Rheology
Storage modulus (G¢) results indicated that mechanical
properties were directly proportional to the concentration
of crosslinker, as expected, because the more the interchain
bonds, the greater the force required to separate them
(Fig. 4). The highest value of G¢ was about 100 kPa and the
lowest 8 kPa.
As concerns the loss modulus (G†), the values obtained are
significantly lower than storage modulii and were also directly
correlated to the concentration of crosslinker. The highest va-
lue in G" corresponded to 20% v/v and was about 0.1 kPa,
about three orders ofmagnitude lower than its storagemodulus.
Both storage and loss modulii were independent of the
frequency of the applied load, thus indicating a strong
elastic behavior of the gels.
No effect was noticed when Sr and Zn, individually or
together, were added to the hydrogels compared with the
samples without added salts (data not shown).
Scanning electron microscope
Deposits were visible with naked eyes on hydrogel sam-
ples, which originally were transparent, after 1 month in SBF.
This phenomenon is appreciable in the SEM picture (Fig. 5),
where the formation of crystals is clearly noticeable.
X-ray diffraction
XRD pattern of pure hydroxyapatite exhibits three high-
intensity peaks located at 2y= 31.7, 32.2, and 32.9.35 The
confirmation that the deposits observed on the surface of the
gels, after immersion in SBF, were hydroxyapatite was
provided by XRD pattern of the gels that revealed the
presence of peaks at about 2y = 32 (Fig. 6). This was not
dependent on either the crosslinker concentration in the
hydrogels or the presence of Sr and Zn.
Ion release
The concentration of Sr in the fluid in contact with hy-
drogels containing 1% v/v crosslinker and 100mM of SrCl2
FIG. 4. Frequency dependence of storage modulus G¢ (a)
and loss modulus G† (b) of hydrogels with different con-
centrations of crosslinker. 1% B 5% ; 10% 6 20%
FIG. 5. Example of SEM image of the hydrogel surface
after immersion in SBF for after 1 month. Bar represent
100 mm. SEM, scanning electron microscope.
FIG. 6. XRD patterns of hydrogels with 20% v/v cross-
linker. XRD, X-ray diffraction.
____ after 0 h after 1 month in SBF
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in the formulation increased during the first 10 days
(Fig. 7a), irrespectively of the presence of ZnCl2. Gels
synthesized with 50mM of Sr in the first 2–3 days exhibited
the same Sr release as those prepared with 100mM, but then
showed a decrease and a further maximum after about
10 days (Fig. 7a); all gels kept releasing Sr for at least
60 days. Hydrogels prepared with 20% v/v crosslinker had a
higher initial Sr release than those formulated with 1% v/v
crosslinker (Fig. 7b) and the Sr concentration gradually
decreased after the first contact with fluids. When 50mM
was added to the hydrogel composition, the Sr concentration
was lower than when 100mM was added (Fig. 7b).
The release of Zn from the gels exhibited a maximum after
about 15–20 days for hydrogels made with 20% v/v cross-
linker and after about 2–3 days for hydrogelsmadewith 1%v/
v crosslinker (Fig. 8); in both cases Zn was recorded for the
duration of the experiment with concentrations gradually
decreasing after the mentioned relative maximum.
Thiazolyl blue tetrazolium bromide (MTT)
The viability of the osteoblast cells seeded on the hydrogels
was assessed with the MTT assay (Fig. 9) that revealed the level of crosslinker did not influence the viability of cells
when Sr or Zn was added ( p> 0.05). When 50mM of SrCl2
was added, no significant difference was noticed across the
concentration of crosslinker ( p> 0.05), whereas with 100mM
of SrCl2 higher metabolic activity was recorded for gels
prepared with 10% and 20% v/v of crosslinker ( p< 0.05).
ZnCl2 did not return significant difference from samples
without this salt ( p> 0.05).
Alizarin Red
The calcium formation resulting from the growth of os-
teoblast cells on the hydrogels was assessed through Ali-
zarin Red staining (Fig. 10); the presence of Sr resulted in an
increase of calcium formation on gels containing 10% and
20% v/v crosslinker, also Zn did not appear to significantly
affect the results ( p > 0.05).
FIG. 7. Concentration of Sr released from hydrogels with
1% (a) and 20% (b) crosslinking concentration. 50mM Sr B Sr 100mM ; Sr 100mM+Zn 1mM
FIG. 8. Concentration of Zn released from hydrogels with
1% () and 20% (B) crosslinking concentration containing
ZnCl2 1mM.
FIG. 9. MTT assay on osteoblast cells grown 21 days on
hydrogels containing combinations of Sr and Zn.
1% 5% 10% 20%
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Antimicrobial test
The antimicrobial activity of themost promising hydrogels
(with 20% v/v of 1,4-butanediol diacrylate), as seen before,
was tested against S. epidermidis and MRSA. Both bacteria
tested are common sources of postorthopedic surgeries36–38;
practically, no antimicrobial activity was exhibited by hy-
drogels not containing either Sr or Zn (Fig. 11) as the apparent
lag phase is typical of cell suspensions with high initial con-
centration.36,39,40 However, when Sr was added to the hy-
drogel formulation, both bacteria displayed lag phases about
2 h longer; this difference was statistically significant
( p < 0.05) and corresponded to a reduction >90% (1 log10) of
the bacteria. The addition of Zn, on the other hand, had a
similar effect on S. epidermidis, but smaller on MRSA;
moreover, no synergistic effect between Sr and Zn was de-
tected as apparent lag phase durations were not statistically
different in case of Sr alone or Zn alone ( p < 0.05).
Discussion
Hydrogels preparation
Injectability, for a hydrogel, requires all reagents em-
ployed in the synthesis to be biologically safe because of the
unreacted molecules possible release from the matrix sub-
sequent to the implantation. In our previous works, we have
developed other hydrogels32,33 with the use of N-N¢-
methylenebisacrylamide as a crosslinking agent; this re-
sulted in the need for dialysis of the prepared hydrogels
because of the adverse effects caused by such molecule;
hence the hydrogels made with this crosslinking agent
were not injectable. In this study, we replaced N-N¢-
methylenebisacrylamide with 1,4-butanediol diacrylate, the
latter is used in dental resins41 and does not require dialysis
of the hydrogels while still providing the same crosslinking
function, therefore, providing the chemical safety property
necessary to be injectable. To establish the feasibility of the
developed hydrogels for injectable bone graft applications
other properties (gelification time and temperature) that are
essential to such characteristic were also investigated. The
gelification needs to occur in a time allowing manipulation
and implantation while the temperature during the gelifica-
tion process must not reach levels causing tissue damage. A
higher concentration of crosslinker appeared to reduce the
setting time (Fig. 1) as expected because a 3D network
between chains is established quicker with increasing ratios
crosslinker to monomers; at the same time, the temperature
rise during gelification was reduced with increasing con-
centration of crosslinker (Fig. 2). This was a consequence of
the monomers/radicals reduced mobility and probability of
reaction caused by the quicker hydrogel hardening com-
pared with the case of lower crosslinker concentration. In
the worst case (1% v/v of crosslinker), the temperature
reached 42C starting from 25C. This increment, which is
still significantly lower than the maximum temperature
reached by bone cement during setting, can still be con-
sidered acceptable for an eventual application in bone tissue
engineering as it is unlikely causing damages to the sur-
rounding tissue, and drugs could also be incorporated into
the gel without thermal degradation. In fact, gels could be
injected at 20C reaching 36C, assuming the same DT. As
concerns the time required to return to initial temperature, it
must be considered that during this experiment the samples
were kept in a plastic tube, surrounded by air; whereas in an
in vivo application, gels would be surrounded by tissues at
37C and this would help them reach body temperature and
remain at it in consequence of the better heat transfer
properties of body fluids compared with air. From an ap-
plication point of view, the gelling time of the hydrogels
presented here is good. In fact, a shorter time, like 1min,
could be difficult to handle as gels could harden before
being properly applied to the site of interest; on the other
hand, long times are not appropriate either as gels could be
injected, but move from the wanted site. In 300 s the gel
could be mixed in a syringe and injected before completely
gelled; for comparison, PMMA bone cement is mixed and
applied in about 2–3min.
FIG. 10. Alizarin Red assay on osteoblast cells grown
21 days on hydrogels containing combinations of Sr and Zn.
1% 5% 10% 20%
FIG. 11. Apparent Lag phase duration of bacteria grown
on hydrogels containing 20% v/v of crosslinker and SrCl2
and ZnCl2. MRSA, methicillin-resistant Staphylococcus
aureus.
MRSA S. epidermidis
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Hydrogels have the capacity of absorbing water when
exposed to an aqueous phase, this capacity is linked to the
flexibility of the gel matrix and the amount of water em-
ployed during the initial formulation.
Similar hydrogels prepared using N-N¢-methylenebisa-
crylamide as crosslinking agent returned a lower water up-
take.32 In this work, we used 1,4-butanediol diacrylate that
presents a longer chain between the two acrylate groups than
N-N¢-methylenebisacrylamide and this is likely to provide
more flexibility and water adsorption capacity to the hy-
drogels presented in this work. Moreover, the presence of
ester instead of amide bonds allows biodegradation of the
biomaterial. The degradation of the hydrogel is a potentially
welcome property as long as the dissolution is not quicker
than the bone formation in the voided space, in this case
mechanical weakening could result in graft failure. The
hydrogels developed in this work does not exhibit a con-
cerning kinetic of hydrolysis as seen in Figure 3.
Currently, one of themain limitations to the use of hydrogels
in orthopedic applications is represented by the weak me-
chanical properties generally exhibited by hydrogels; this limits
many applications to no load-bearing locations.42 The values of
G¢ (about 0.1MPa) obtained for the hydrogels developed in this
work (Fig. 4) were encouragingly high for hydrogels. They
exhibited similar rheological properties to PMMA bone ce-
ment36 or to mineralized acrylate-based hydrogels through re-
action–diffusion methods resulting in the formation of beta-
TCP inside the hydrogel matrix.33 Hence, they are likely to be
suited for implantation in load-bearing sites.
Growth of osteoblasts on hydrogels
Assessment of apatite formation on a biomaterial fol-
lowing exposure to SBF solution is the standard method to
determine the capacity of a material to stimulate bone for-
mation.43 We observed the formation of crystals on hydro-
gel surface through SEM (Fig. 5) and assessed them to be
hydroxyapatite using XRD (Fig. 6), thus providing conclu-
sive evidence of the suitability of the hydrogels presented in
this work to be employed as bone graft material.
Bones are composite materials that are predominantly made
of collagen and hydroxyapatite.44 a-TCP is sometimes
added to synthetic bone graft materials45,46 as it is biocom-
patible, improves cell proliferation,45 and hydrolyses to hy-
droxyapatite,47 thus inducing the biomaterial to simulate the
mineralogical composition of bone. Beta-TCP has also been
added to bone graft material48,49; we chose a-TCP as it has
higher solubility than beta-TCP, hence a quicker degrada-
tion.50 The concentration use in this work (0.8% w/w) was
similar to other works employing calcium phosphate in hy-
drogels for bone replacement49 and an order of magnitude
lower than Li et al.45
Strontium34,51–55 and zinc56 are known to support osteo-
blast growth and have been added to hydrogels developed for
orthopedic applications,34 on the surface of bioglasses,57,58 on
titanium surfaces,59 or calcium phosphate films.60 Release of
these ions from the solid matrix is also required to stimulate
osteoblast growth. Themaximum concentrations of SrCl2 and
ZnCl2 added to the gelification mixture were chosen in the
same range of those used34 to crosslink an alginate base hy-
drogel and resulted in concentrations of ions in the release
media after the first few days in the same order of magnitude.
The release of these ions from the hydrogels did not follow
Fick’s law (Figs. 7 and 8) as the swelling of the gels is also
involved in the mass transfer of ions from the solid matrix of
the gel to the surrounding fluid; this is particularly evident in
the gels containing 1% crosslinker, where a maximum con-
centration of Sr was recorded after about 10 days and of Zn
after 15–20 days of contact with fluid. This phenomenon is a
consequence of these gels swelling more than those con-
taining 20% v/v crosslinker (Fig. 3); also the concentration of
ions in the gels depleted from the level of the initial synthesis
(t= 0) and as such, the concentration of ions (both Sr and Zn)
in the fluid, during the first days of contact, is lower for the
hydrogels with lower levels of crosslinker. In our hydrogels,
Sr provided the expected activity toward bone forming cells
(Figs. 9 and 10), while Zn did not. The different concentra-
tions of these two ions in themedium after release can account
for such result.
Hydrogels prepared with 20% v/v of crosslinker with Sr
and Zn appeared to be the most effective as they returned
the best mechanical properties and osteoblast growth and,
therefore, they were selected for further investigation.
To improve cell adhesion on orthopedic materials, RGD
(arginine-glycine-aspartic acid) sequences can be grafted to
the surface61 or conjugated to hydrogel constituents.34
However, these do not appear essential as osteoblast adhesion
has been observed on surfaces not exhibiting such features
like those presented in this work and others i.e., PMMA bone
cements. We chose not to pursue this approach because of the
increased complexity (measurable in term product unit fab-
rication cost) induced by additional preparation as the in-
corporation of TCP in the hydrogel is likely to play a role in
facilitating osteoblast adhesion and proliferation.48,62,63
Antimicrobial properties
Strontium is known to interfere with bacterial growth and
has been used as a possible strategy in the fight against
orthopedic infections64,65; therefore, we hypothesized that
the hydrogels containing these ions could also exhibit the
capacity of interfering with bacterial infections. We em-
ployed the indirect method developed by Bechert et al.66 that
is based on the duration of the apparent lag phase of the cells
grown on the material measured through turbidity. The lower
the cell concentration on the sample in contact with the ma-
terial, the longer the apparent lag phase (time required for the
cell to grow to the threshold concentration of detection
through turbidity); furthermore, assuming a doubling time of
30min, an increment in apparent lag phase of 1.5 h is equiv-
alent to a reduction of cell concentration of 1 log10 because
log210= 3.3.36 Evidence of lethal activity against pathogenic
bacteria was observed (Fig. 11). The different response of
these two species related to the intrinsic susceptibility of such
bacteria and expected asMRSA is usually more resistant than
S. epidermidis to antimicrobial agents.36,39,40
However, although the antimicrobial activity is not com-
parable to antibiotics or silver,36,39,40 the presence of Sr and
Zn could be helpful in lowering the risk of bacterial infections
that are always a possible threat after surgery. Because of the
nonantibiotic nature of the antimicrobial compounds added to
the hydrogels (Sr and Zn), this approach is also well in line
with the effort against the growing concern posed by rising
antibiotic resistance among pathogens.
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Conclusions
The novel hydrogels presented showed very interesting
properties. First of all the mechanical properties of the hy-
drogels are unique, with elevated storage modulus and low
viscous modulus, which can be helpful for bone tissue ap-
plications in load-bearing situations currently precluded to
many hydrogels. Temperature increase during polymeriza-
tion is also acceptable. Even more, the addition of strontium
and zinc not only improved the growth and calcium pro-
duction of osteoblast cells, but also hampered the growth of
infection causing bacteria like S. epidermidis and MRSA.
Another important quality of the gel is the capability of
forming hydroxyapatite deposits, critical in the developing
process of the mineralized extracellular matrix in bone tis-
sue applications, already after 1 month. The joint actions of
ions supporting osteoblast growth (Sr and Zn) and the ca-
pability of forming hydroxyapatite deposits, due to the gel
itself, can lead to a better and quicker formation of extra-
cellular matrix.
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